Macquarie rates CDA as Outperform (1) -
The company has indicated FY22 has commenced with existing businesses in line and record profitability likely to be boosted by DTC and Zetron.
The the pandemic boosted FY21 revenue by $15-20m and the current year should benefit from the launch of the GPX6000 detector in developed countries.
Macquarie reduces the target to $15.20 from $17.50 to reflect a lower organic growth outlook in the core detection business. Outperform maintained.
Macquarie rates CDA as Outperform (1) -The company has indicated...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$20.26 |
Change
0.560(2.84%) |
Mkt cap ! $3.678B | |||
| Open | High | Low | Value | Volume |
| $19.59 | $20.26 | $19.57 | $23.65M | 1.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5420 | $20.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.27 | 965 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| CDA (ASX) Chart |